参考文献/References:
[1]Weinberger DR.Thinking About Schizophrenia in an Era of Genomic Medicine[J].The American Journal of Psychiatry,2019,176(1):12. [2]Tanya H,Katie L,Chen Y,et al.A decade in psychiatric GWAS research[J].Molecular Psychiatry,2019,24(3):378-389. [3]Brennand K,Marchetto M,Benvenisty N,et al.Creating Patient-Specific Neural Cells for the In Vitro Study of Brain Disorders[J].Stem Cell Reports,2015,5(6):933-945. [4]O’Donovan MC,Williams NM,Owen MJ.Recent advances in the genetics of schizophrenia[J].Human Molecular Genetics,2003(suppl_2):R125. [5]Malashenkova IK,Krynskiy SA,Ogurtsov DP,et al.A role of the immune system in the pathogenesis of schizophrenia[J].Zh Nevrol Psikhiatr Im S S Korsakova,2018,118(12):72-80. [6]Felger JC,Miller AH.Neurotherapeutic implications of brain-immune interactions[J].Neuropsychopharmacology,2014,39(1):242-243. [7]Morris G,Berk M,Galecki P,et al.The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases[J].Molecular Neurobiology,2016,53(2):1195-1219. [8]Frydecka D,Krzystek-Korpacka M,Lubeiro A,et al.Profiling inflammatory signatures of schizophrenia:a cross-sectional and meta-analysis study[J].Brain Behavior&Immunity,2018(71):28-36. [9]Kéri S,Szabó C,Kelemen O.Antipsychotics influence Toll-like receptor(TLR)expression and its relationship with cognitive functions in schizophrenia[J].Brain Behavior&Immunity,2017(62):256-264. [10]Kozlowska E,Agier J,Wysokiński A,et al.The expression of toll-like receptors in peripheral blood mononuclear cells is altered in schizophrenia[J].Psychiatry Research,2019(272):540-550. [11]Xiang N,K Shiho, Kohei T,et al.The Innate Immune Receptors TLR2/4 Mediate Repeated Social Defeat Stress-Induced Social Avoidance through Prefrontal Microglial Activation[J].Neuron,2018(99):S0896627318305312. [12]Cohen OS,Weickert TW,Hess JL,et al.A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples[J].Molecular Psychiatry,2016,21(7):975-982. [13]Wang HY,Liu Y,Yan JW,et al.Gene polymorphisms of DISC1 is associated with schizophrenia:Evidence from a meta-analysis[J].Progress in Neuro-Psychopharmacology and Biological Psychiatry,2018(81):64-73. [14]Vinita J,Miriam G,Susanne W,et al.Neuregulin 1(NRG1)gene expression predicts functional outcomes in individuals at clinical high-risk for psychosis[J].Psychiatry Research,2018(266):143-146. [15]李婷,康敏敏,黄正元,等.首发精神分裂症血清神经调节蛋白-1、脑电图γ活动及认知功能相关研究[J].中国神经精神疾病杂志,2019,45(7):390-394. [16]Sacchi S.D-Serine metabolism: new insights into the modulation of D-amino acid oxidase activity[J].Biochemical Society Transactions,2013,41(6):1551-1556. [17]Liu YL,Wang SC,Hwu HG,et al.Haplotypes of the D-Amino Acid Oxidase Gene Are Significantly Associated with Schizophrenia and Its Neurocognitive Deficits[J].Plos One,2016,11(3):e0150435. [18]Konopaske GT,Balu DT,Presti KT,et al.Dysbindin-1 contributes to prefrontal cortical dendritic arbor pathology in schizophrenia[J].Schizophrenia Research,2018:S0920996418302561. [19]Bakanidze G,Brandl EJ,Hutzler C,et al.Association of Dystrobrevin-Binding Protein 1 Polymorphisms with Sustained Attention and Set-Shifting in Schizophrenia Patients[J].Neuropsy Chobiology,2016,74(1):41-47. [20]Ota VK,Gadelha A,Assuncao IB,et al.ZDHHC8 gene may play a role in cortical volumes of patients with schizophrenia[J].Schizophrenia Research,2013,145(1-3):33-35. [21]Moraes LS,Santos A,Ferreira-Fernandes H,et al.Lack of association between COMT Val158Met and ZDHHC8 rs175174 polymorphisms and susceptibility to schizophrenia in a Brazilian population[J].Psychiatr Genet,2017,27(5):197-198. [22]Demily C,Legallic S,Bou J,et al.ZDHHC8 single nucleotide polymorphism rs175174 is not associated with psychiatric features of the 22q11 deletion syndrome or schizophrenia[J].Psychiatric Genetics,2007,17(5):311-312.
相似文献/References:
[1]邹超杰,程宇琪.肠道微生物在精神分裂症中的研究进展[J].医学信息,2018,31(02):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
ZOU Chao-jie,CHENG Yu-qi.Progress in the Study of Intestinal Microorganism in Schizophrenia[J].Medical Information,2018,31(16):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
[2]张 健,江 芮.生活技能训练对精神分裂症缓解期患者日常生活能力的影响[J].医学信息,2018,31(03):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
ZHANG Jian,JIANG Rui.Effect of Life Skills Training on Daily Living Ability of Patients with Schizophrenia in Remission Staged[J].Medical Information,2018,31(16):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
[3]沈雪梅.齐拉西酮与奥氮平治疗首发精神分裂症
疗效及糖脂代谢的影响观察[J].医学信息,2018,31(06):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
SHEN XUE-mei.The Effect of Ziprasidone and Olanzapine in the Treatment of First Episode Schizophrenia and the Effect of Glycolipid Metabolism[J].Medical Information,2018,31(16):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
[4]陈功琦,梁道博.利培酮联合舍曲林治疗精神分裂症阴性症状
疗效和安全性的Meta分析[J].医学信息,2018,31(10):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
CHEN Gong-qi,LIANG Dao-bo.Meta Analysis of Efficacy and Safety of Risperidone Combined with Sertraline in the Treatment of Schizophrenia with Negative Symptoms[J].Medical Information,2018,31(16):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
[5]孙来顺.氨磺必利与利培酮对精神分裂症患者内分泌及糖脂代谢的影响[J].医学信息,2022,35(10):137.[doi:10.3969/j.issn.1006-1959.2022.10.033]
SUN Lai-shun.Effects of Amisulpride and Risperidone on Endocrine And Glucose and Lipid Metabolism in Patients with Schizophrenia[J].Medical Information,2022,35(16):137.[doi:10.3969/j.issn.1006-1959.2022.10.033]
[6]孙占娟.精神分裂症患者的认知康复治疗进展[J].医学信息,2018,31(13):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
SUN Zhan-juan.Progress in Cognitive Rehabilitation Therapy of Schizophrenia Patients[J].Medical Information,2018,31(16):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
[7]吴金丽.阿立哌唑的临床应用[J].医学信息,2018,31(14):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
WU Jin-li.Clinical Application of Aripiprazole[J].Medical Information,2018,31(16):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
[8]宋典雄.激励理论指导下的护理干预对精神分裂症患者的影响[J].医学信息,2018,31(18):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
SONG Dian-xiong.The Effect of Nursing Intervention under the Guidance of Motivation Theory on Patients with Schizophrenia[J].Medical Information,2018,31(16):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
[9]凌 梅,刘静芳.精神分裂症患者研究伙伴的相关研究进展[J].医学信息,2018,31(19):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
LING Mei,LIU Jing-fang.Progress in Research on Research Partners in Patients with Schizophrenia[J].Medical Information,2018,31(16):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
[10]韩佳睿,张 苹,张 媛.迟发性运动障碍与DNA甲基化之间关系的研究进展[J].医学信息,2018,31(20):32.[doi:10.3969/j.issn.1006-1959.2018.20.010]
HAN Jia-rui,ZHANG Ping,ZHANG Yuan.Advances in Research on the Relationship between Tardive Dyskinesia and DNA Methylation[J].Medical Information,2018,31(16):32.[doi:10.3969/j.issn.1006-1959.2018.20.010]